Amwill Health Care Limited approved investments of ₹3 Crore into two Alternative Investment Funds. The company will invest ₹1.50 Crore each in Vivriti Vihaan Trust and Neo Income Plus Fund III.
Amwill Health Care Ltd announced a new treasury strategy, approving aggregate investment limits totaling ₹33 Crore across debt, equity, and mutual fund segments for surplus capital.
Amwill Health Care Ltd approved the re-appointment of Mr. Tarun Gandhi and Mr. Anand Gandhi as Managing Directors. The Board also scheduled the upcoming 09th AGM.
Amwill Health Care Limited has issued a notice for its 9th Annual General Meeting, scheduled for August 14, 2026, to transact ordinary and special business.
Amwill Health Care re-appointed Mr. Tarun Gandhi and Mr. Anand Gandhi as Managing Directors for five years. The Board also convened the 9th AGM for August 14, 2026.
Amwill Health Care approved FY26 audited financial results and recommended a ₹0.50 per share final dividend. Annual revenue reached ₹45.49 Crore with a net profit of ₹11.42 Crore.
Amwill Health Care declared non-applicability of the Annual Secretarial Compliance Report for FY26. As a BSE SME entity, it is exempt under Regulation 15(2).
Amwill Health Care Ltd provided an update regarding a February 2026 cyber security incident that caused data loss in its Structured Digital Database. The company has reconstructed and re-entered all required UPSI entries from July 2025 onwards, as confirmed by a professional certificate from a Company Secretary.